Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015)
Támogató: NKFIH
(SNN 138407)
Szakterületek:
Állatorvosi tudományok
Breast cancer, a complex disease with a significant prevalence to form metastases,
necessitates novel therapeutic strategies to improve treatment outcomes. Here, we
present the results of a comparative molecular study of primary breast tumours, their
metastases, and the corresponding primary cell lines using Desorption Electrospray
Ionisation (DESI) and Laser-Assisted Rapid Evaporative Ionisation Mass Spectrometry
(LA-REIMS) imaging. Our results show that ambient ionisation mass spectrometry technology
is suitable for rapid characterisation of samples, providing a lipid- and metabolite-rich
spectrum within seconds. Our study demonstrates that the lipidomic fingerprint of
the primary tumour is not significantly distinguishable from that of its metastasis,
in parallel with the similarity observed between their respective primary cell lines.
While significant differences were observed between tumours and the corresponding
cell lines, distinct lipidomic signatures and several phospholipids such as PA(36:2),
PE(36:1), and PE(P-38:4)/PE(O-38:5) for LA-REIMS imaging and PE(P-38:4)/PE(O-38:5),
PS(36:1), and PI(38:4) for DESI-MSI were identified in both tumours and cells. We
show that the tumours’ characteristics can be found in the corresponding primary cell
lines, offering a promising avenue for assessing tumour responsiveness to therapeutic
interventions. A comparative analysis by DESI-MSI and LA-REIMS imaging revealed complementary
information, demonstrating the utility of LA-REIMS in the molecular imaging of cancer.